Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Clinical trial NCT04803318 · RECRUITING

Trial details

NCT number: NCT04803318
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Hepatocellular Carcinoma

Start date: 2021-01-01
Primary completion: 2029-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.